Myocea, Inc.
PrivateCompany Overview
Myocea, Inc. is a biotechnology company that develops therapeutics and cell-based models for the treatment of neuromuscular disorders, specifically facioscapulohumeral muscular dystrophy (FSHD).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
neuromuscular diseaseFSHDFacioscapulohumeral Muscular Dystrophyregenerative medicinedisease modelingdrug discoveryskeletal muscle cellssatellite-like cellsSLCscell culture mediasmall molecule therapeuticsin vitro modelsorgan-on-a-chipbiotech reagentsrare disease research
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Myocea, Inc. Comparables
Compare Myocea, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Altay Therapeutics | 82% | |
| Facio Therapies | 77% | |
| Sanofi | 74% | |
Myocea, Inc. Funding Rounds
Historical fundraising activity
Myocea, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Myocea, Inc.'s valuation, stock price, and market status.
Firmographic Details
HeadquartersSan Diego, California
Employee Range1
Year Founded2019
Last Funding—
See something wrong or outdated?